Source:http://linkedlifedata.com/resource/pubmed/id/11380797
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-5-30
|
pubmed:abstractText |
Current evidence suggests that increased expression of Th1-associated cytokines is important for immune-mediated eradication of hepatitis C infection, while an increase in Th2-associated cytokines is associated with persistence of infection. In this study we evaluated the effects of thymosin-alpha1 (TA1), a naturally occurring thymic peptide, and interferon-alpha (IFN-alpha) on cytokine production in peripheral blood mononuclear cells from untreated patients with chronic hepatitis C. We examined the effect of incubation with TA1, IFN-alpha, or both, on production of Th1-associated cytokines (IL-2, IFN-gamma), Th2-associated cytokines (IL-4, IL-10), and synthesis of the antiviral protein 2',5'-oligoadenylate synthetase. TA1 treatment induced a significant increase in production of IL-2 and 2',5'-oligoadenylate synthetase. Smaller increases were also seen after treatment with IFN-alpha, while incubation with TA1 and IFN-alpha together led to an additive or synergistic effect. Incubation with TA1 resulted in a decrease in IL-4 and IL-10, whereas IFN-alpha increased these cytokines. The addition of TA1 to IFN-alpha significantly reversed this IFN-alpha-induced increase. Hence, TA1 treatment could benefit patients with hepatitis C infection by increasing the Th1-type response, fundamental for sustained clearance of hepatitis C; and by decreasing the Th2-type response, associated with persistence of viraemia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2',5'-Oligoadenylate Synthetase,
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Concanavalin A,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Thymosin,
http://linkedlifedata.com/resource/pubmed/chemical/thymalfasin
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1352-0504
|
pubmed:author |
pubmed-author:AndreonePP,
pubmed-author:BernardiMM,
pubmed-author:BiselliMM,
pubmed-author:CursaroCC,
pubmed-author:FellingDD,
pubmed-author:FerriEE,
pubmed-author:GasbarriniGG,
pubmed-author:GramenziAA,
pubmed-author:MargottiMM,
pubmed-author:MartiniSS,
pubmed-author:TalaricoSS,
pubmed-author:TuthillCC
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
194-201
|
pubmed:dateRevised |
2005-6-17
|
pubmed:meshHeading |
pubmed-meshheading:11380797-2',5'-Oligoadenylate Synthetase,
pubmed-meshheading:11380797-Adjuvants, Immunologic,
pubmed-meshheading:11380797-Adult,
pubmed-meshheading:11380797-Antiviral Agents,
pubmed-meshheading:11380797-Cells, Cultured,
pubmed-meshheading:11380797-Concanavalin A,
pubmed-meshheading:11380797-Cytokines,
pubmed-meshheading:11380797-Female,
pubmed-meshheading:11380797-Hepacivirus,
pubmed-meshheading:11380797-Hepatitis C, Chronic,
pubmed-meshheading:11380797-Humans,
pubmed-meshheading:11380797-Interferon-alpha,
pubmed-meshheading:11380797-Leukocytes, Mononuclear,
pubmed-meshheading:11380797-Male,
pubmed-meshheading:11380797-Middle Aged,
pubmed-meshheading:11380797-Th1 Cells,
pubmed-meshheading:11380797-Th2 Cells,
pubmed-meshheading:11380797-Thymosin
|
pubmed:year |
2001
|
pubmed:articleTitle |
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.
|
pubmed:affiliation |
Semeiotica Medica, Dipartimento di Medicina Interna, Cardioangiologia ed Epatologia, Università di Bologna, Policlinico S. Orsola, Via Massarenti, 9-40138 Bologna, Italy. andreone@med.unibo.it
|
pubmed:publicationType |
Journal Article
|